NSCLC, metastatic CheckMate 026: A phase 3 trial of nivolumab vs investigator's choice (IC) of platinum-based doublet chemotherapy (PT-DC) as first-line therapy for stage iv/recurr... von Socinski, M., Creelan, B., Horn, L., Reck, M., Paz-Ares, L., Steins, M., Felip, E., van den Heuvel, M., Ciuleanu, T.E., Badin, F., Ready, N., Hiltermann, T.J.N., Nair, S., Juergens, R., Peters, S., Minenza, E., Geese, W.J., Bhagavatheeswaran, P., Chen, A., Carbone, D.P.

Volltext

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer von Hellmann, Matthew D, Paz-Ares, Luis, Bernabe Caro, Reyes, Zurawski, Bogdan, Kim, Sang-We, Carcereny Costa, Enric, Park, Keunchil, Alexandru, Aurelia, Lupinacci, Lorena, de la Mora Jimenez, Emmanuel, Sakai, Hiroshi, Albert, Istvan, Vergnenegre, Alain, Peters, Solange, Syrigos, Konstantinos, Barlesi, Fabrice, Reck, Martin, Borghaei, Hossein, Brahmer, Julie R, O’Byrne, Kenneth J, Geese, William J, Bhagavatheeswaran, Prabhu, Rabindran, Sridhar K, Kasinathan, Ravi S, Nathan, Faith E, Ramalingam, Suresh S

Volltext

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden von Hellmann, Matthew D, Ciuleanu, Tudor-Eliade, Pluzanski, Adam, Lee, Jong Seok, Otterson, Gregory A, Audigier-Valette, Clarisse, Minenza, Elisa, Linardou, Helena, Burgers, Sjaak, Salman, Pamela, Borghaei, Hossein, Ramalingam, Suresh S, Brahmer, Julie, Reck, Martin, O’Byrne, Kenneth J, Geese, William J, Green, George, Chang, Han, Szustakowski, Joseph, Bhagavatheeswaran, Prabhu, Healey, Diane, Fu, Yali, Nathan, Faith, Paz-Ares, Luis

Volltext

9001 ORAL A Retrospective Subgroup Analysis of EGFR Immunohistochemistry (IHC) Expression by Histo-Score Correlated to Outcomes From the BMS099 1st Line Phase III NSCLC Trial of Ce... von Lynch, T, Bhagavatheeswaran, P, Mukhopadhyay, P, Khambata-Ford, S, Harbison, C.T

Volltext

75TiP A multicenter, open-label, phase II trial evaluating the safety and efficacy of folate receptor alpha (FRα) antibody-drug conjugate (ADC) farletuzumab ecteribulin (FZEC) in p... von Planchard, D., Paz-Ares, L., Spira, A., Felip, E., McCune, S., Cascella, T., Dennie, J., Bhagavatheeswaran, P., Dumitru, C., Borghaei, H.

Volltext

LBA3 Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (aNSCLC): CheckMate 227 - part 2 fi... von Paz-Ares, L., Ciuleanu, T.E., Yu, X., Salman, P., Pluzanski, A., Nagrial, A., Havel, L., Kowalyszyn, R., Audigier-Valette, C., Wu, Y.-L., Borghaei, H., Hellmann, M.D., Brahmer, J., Reck, M., Ramalingam, S., Zhang, L., Bhagavatheeswaran, P., Nathan, F.E., O'Byrne, K.J.

Volltext

PS2 CheckMate 227: Nivolumab + Ipilimumab vs Chemotherapy as 1L Treatment for Advanced NSCLC With High Tumor Mutational Burden von Mathias, C., Reck, M., Hellmann, M., Ramalingam, S., Brahmer, J., O'Byrne, K., Bhagavatheeswaran, P., Nathan, F., Borghaei, H., Paz-Ares, L.

Volltext

LBA4_PRNivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): Chec... von Peters, S, Ramalingam, S S, Paz-Ares, L, Bernabe Caro, R, Zurawski, B, Kim, S-W, Alexandru, A, Lupinacci, L, de la Mora Jimenez, E, Sakai, H, Albert, I, Vergnenegre, A, Reck, M, Borghaei, H, Brahmer, J R, O’Byrne, K J, Geese, W J, Bhagavatheeswaran, P, Nathan, F E, Hellmann, M D

Volltext

Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 2... von Peters, S., Ramalingam, S.S., Paz-Ares, L., Bernabe Caro, R., Zurawski, B., Kim, S.-W., Alexandru, A., Lupinacci, L., de la Mora Jimenez, E., Sakai, H., Albert, I., Vergnenegre, A., Reck, M., Borghaei, H., Brahmer, J.R., O’Byrne, K.J., Geese, W.J., Bhagavatheeswaran, P., Nathan, F.E., Hellmann, M.D.

Volltext

LBA4_PR - Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): C... von Peters, S., Ramalingam, S.S., Paz-Ares, L., Bernabe Caro, R., Zurawski, B., Kim, S.-W., Alexandru, A., Lupinacci, L., de la Mora Jimenez, E., Sakai, H., Albert, I., Vergnenegre, A., Reck, M., Borghaei, H., Brahmer, J.R., O’Byrne, K.J., Geese, W.J., Bhagavatheeswaran, P., Nathan, F.E., Hellmann, M.D.

Volltext

OA05.06 CheckMate 227: Patient-Reported Outcomes of First-Line Nivolumab + Ipilimumab in High Tumor Mutational Burden Advanced NSCLC von Brahmer, J., Schenker, M., Lee, K.H., Provencio, M., Nishio, M., Lesniewski-Kmak, K., Sangha, R., Ahmed, S., Raimbourg, J., Feeney, K., Corre, R., Franke, F., Richardet, E., Penrod, J., Yuan, Y., Nathan, F., Bhagavatheeswaran, P., De Rosa, M., Taylor, F., Lawrance, R., Reck, M.

Volltext

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer von Carbone, David P, Reck, Martin, Paz-Ares, Luis, Creelan, Benjamin, Horn, Leora, Steins, Martin, Felip, Enriqueta, van den Heuvel, Michel M, Ciuleanu, Tudor-Eliade, Badin, Firas, Ready, Neal, Hiltermann, T. Jeroen N, Nair, Suresh, Juergens, Rosalyn, Peters, Solange, Minenza, Elisa, Wrangle, John M, Rodriguez-Abreu, Delvys, Borghaei, Hossein, Blumenschein, George R, Villaruz, Liza C, Havel, Libor, Krejci, Jana, Corral Jaime, Jesus, Chang, Han, Geese, William J, Bhagavatheeswaran, Prabhu, Chen, Allen C, Socinski, Mark A

Volltext

Innovative Technologies for Developing Rural Pottery Industry von Bhagavatheeswaran

Volltext

Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial von Fizazi, Karim, Retz, Margitta, Petrylak, Daniel P, Goh, Jeffrey C, Perez-Gracia, Jose, Lacombe, Louis, Zschäbitz, Stefanie, Burotto, Mauricio, Mahammedi, Hakim, Gravis, Gwenaelle, Bastos, Diogo Assed, McCune, Steven L, Vázquez Limón, Juan Carlos, Kwan, Edmond M, Castellano, Daniel, Fléchon, Aude, Saad, Fred, Grimm, Marc-Oliver, Shaffer, David R, Armstrong, Andrew J, Bhagavatheeswaran, Prabhu, Amin, Neha P, Ünsal-Kaçmaz, Keziban, Wang, Xuya, Li, Jun, Loehr, Andrea, Pachynski, Russell K

Volltext

Abstract CT082: Impact of tumor mutation burden on the efficacy of first-line nivolumab in stage iv or recurrent non-small cell lung cancer: An exploratory analysis of CheckMate 02... von Peters, Solange, Creelan, Benjamin, Hellmann, Matthew D., Socinski, Mark A., Reck, Martin, Bhagavatheeswaran, Prabhu, Chang, Han, Geese, William J., Paz-Ares, Luis, Carbone, David P.

Volltext

Rural Technology Development and Delivery von Chigullapalli, Sreenivas, Susha Lekshmi, S. U, Deshpande, Abhijit P

Volltext

Founding of the Global Health Film initiative von Fitchett, Joseph R, Bhagavatheeswaran, Lalitha, Dahab, Maysoon, Haines, Andy P, Edmunds, W John, Global Health Film initiative

Volltext

Founding of the Global Health Film initiative von Fitchett, Joseph R, Bhagavatheeswaran, Lalitha, Dahab, Maysoon, Haines, Andy P, Edmunds, W John

Volltext

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer von Carbone, David P, Reck, Martin, Paz-Ares, Luis, Creelan, Benjamin, Horn, Leora, Steins, Martin, Felip, Enriqueta, van den Heuvel, Michel M, Ciuleanu, Tudor-Eliade, Badin, Firas, Ready, Neal, Hiltermann, T. Jeroen N, Nair, Suresh, Juergens, Rosalyn, Peters, Solange, Minenza, Elisa, Wrangle, John M, Rodriguez-Abreu, Delvys, Borghaei, Hossein, Blumenschein, George R, Villaruz, Liza C, Havel, Libor, Krejci, Jana, Corral Jaime, Jesus, Chang, Han, Geese, William J, Bhagavatheeswaran, Prabhu, Chen, Allen C, Socinski, Mark A

Volltext

The barriers and enablers to education among scheduled caste and scheduled tribe adolescent girls in northern Karnataka, South India: A qualitative study von Bhagavatheeswaran, L, Nair, S, Stone, H, Isac, S, Hiremath, T, T, R, Vadde, K, Doddamane, M, Srikantamurthy, HS, Heise, L, Watts, C, Schweisfurth, M, Bhattacharjee, P, Beattie, TS

Volltext